» Articles » PMID: 498023

A Report of the Workshops on the Current Status of the Histologic Grading of Prostate Cancer

Overview
Journal Cancer
Publisher Wiley
Specialty Oncology
Date 1979 Oct 1
PMID 498023
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

A national multidisciplinary study of four major systems for the histological grading of primary prostatic cancer was completed during 1978. In a series of workshops culminating in a final review, criteria of grading were critically assessed against the background of patient survival data. The overall consensus was that the Gleason system should tentatively be adopted as the pathologic reference point for classifying patients. This system can be used in conjunction with other systems. It seems definable, reproducible, reasonably simple, and has clinical relevance as judged by correlations with patient survival. Further study may demonstrate advantages from incorporation of the nuclear or cytologic characteristics of tumor cells into the Gleason system. New techniques of acid phosphatase determination, bone scans, and assessment of the regional lymph nodes should provide better staging criteria for correlation with primary tumor histology in the furture. These workshops presented a unique opportunity for representative clinicians and pathologists in the United States to express their viewpoints in a comprehensive fashion on this timely and important topic.

Citing Articles

Clinical significance of prospectively assigned Gleason tertiary pattern 4 in contemporary Gleason score 3+3=6 prostate cancer.

Doshi C, Vacchio M, Attwood K, Murekeyisoni C, Mehedint D, Badkhshan S Prostate. 2016; 76(8):715-21.

PMID: 26880312 PMC: 5437842. DOI: 10.1002/pros.23166.


Gleason 6 Prostate Cancer: Translating Biology into Population Health.

Eggener S, Badani K, Barocas D, Barrisford G, Cheng J, Chin A J Urol. 2015; 194(3):626-34.

PMID: 25849602 PMC: 4551510. DOI: 10.1016/j.juro.2015.01.126.


Investigation of risk factors for prostate cancer patients with bone metastasis based on clinical data.

Yamada Y, Naruse K, Nakamura K, Taki T, Tobiume M, Zennami K Exp Ther Med. 2012; 1(4):635-639.

PMID: 22993586 PMC: 3445889. DOI: 10.3892/etm_00000099.


Well-differentiated prostate cancer in core biopsy specimens may be associated with extraprostatic disease.

Cury J, Coelho R, Srougi M Sao Paulo Med J. 2008; 126(2):119-22.

PMID: 18553035 PMC: 11026029. DOI: 10.1590/s1516-31802008000200010.


Prostate Cancer - Old Problems and New Approaches. (Part II. Diagnostic and Prognostic Markers, Pathology and Biological Aspects).

Honn K, Aref A, Chen Y, Cher M, Crissman J, Forman J Pathol Oncol Res. 1996; 2(3):191-211.

PMID: 11173606 DOI: 10.1007/BF02903527.